Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Senomyx, Solae savory soy

This article was originally published in The Tan Sheet

Executive Summary

A partnership by soy protein supplier Solae and flavor technology developer Senomyx aims to improve soy protein's taste through the development of bitter blockers. Since April 2007, scientists from both firms have collaborated to determine the bitter components of soy protein and discovered new ingredients to modulate how taste receptors respond, the companies say Sept. 15. Under a licensing agreement, Solae will retain exclusive worldwide rights to use the soy protein flavor ingredients in all food and beverages, with Senomyx receiving royalties based on sales. San Diego-based Senomyx previously sought bitter-blocking agents for use in OTC pediatric products (1"The Tan Sheet" Jan. 16, 2006, p. 13). St. Louis-based Solae once pursued a qualified health claim linking soy protein to cancer prevention, but withdrew its petition in 2005 (2"The Tan Sheet" Oct. 31, 2005, In Brief)

You may also be interested in...



SupplySide West New Products In Brief

Frutarom sticks probiotic in functional gum: The Israeli flavor and ingredient firm offers an oral-cavity probiotic strain with reported immune-boosting properties, BLIS K12, as an ingredient for functional chewing gums. BLIS K12 promotes ear, nose and throat health and can also help prevent bad breath, Frutarom said in an Oct. 30 release. The company showcased the probiotic at the SupplySide West trade show Nov. 12 in Las Vegas in a 20-mg gum prototype made via a cold-press process by Tab Labs

Senomyx Seeks Alternatives To “Spoonful Of Sugar” To Make Meds Go Down

Senomyx expects to develop bitter flavor-blocking agents for use in pediatric OTC products in 2006, the biotechnology firm stated during a Jan. 12 presentation to investors

Teva Takes On Amneal With Second US NuvaRing Rival

Teva has launched its generic version of NuvaRing in the US, adding a second rival generic to the market that already includes Amneal, as well as an authorized generic version from Prasco.

Topics

UsernamePublicRestriction

Register

LL033172

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel